FDA Accepting Comments on Guidance for Cannabis Pharmaceutical Research

Ganjapreneur
By TG BranfaltJul 22, 2020, 11:53 am187 pts
In preliminary U.S. Food and Drug Administration guidance on cannabis research released Tuesday, clinical researchers would be allowed to use any cannabis from any source in studies so long as it’s classified as industrial hemp (contains less than 0.3 percent THC). Researchers seeking cannabis over the hemp…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

How to Qualify for Medicinal Cannabis in New Jersey 68

Christina Lake Cannabis files 15-month report with increasing revenue, declining losses 66

Collective Project Launches Portfolio of Hemp-Derived THC Beverages in 25 States 65

Last Week in Weed: July 1- July 8, 2025 64

Auxly Cannabis reaches ‘turning point’ with closing of 2 transactions 64

Oregon Police Improperly Used Aerial Camera To Bust Marijuana Grow, State Appeals Court Says 63

Texas: Dallas Officials Halt Implementation of Voter-Approved Marijuana Depenalization Ordinance 62

4 Pitfalls to Avoid When Seeking a Cannabis Trademark (and Tips to Avoid Them) 61

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.